InsiderSignalSign in
← Insider buys

Mary Dibiase has sold XFOR and made no open-market buys since Nov 2023

COO at X4 Pharmaceuticals, Inc.

SEC CIK 0001880179 · Filings on SEC.gov ↗

$0Bought
$88KSold
NoneLast buy

Every filing

2 filings since Nov 2023, newest first

XFORSell

X4 Pharmaceuticals, Inc

COO

$38K−13.0%Oct 8
XFORSell

X4 Pharmaceuticals, Inc

COO

$49K−18.0%Nov 3

Filings come from SEC EDGAR. Not investment advice.